lacosamide adroiq
extrovis eu ltd. - lacosamide - epilepsie - van anti-epileptica, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide teva 50 mg filmomh. tabl.
teva b.v. - lacosamide 50 mg - filmomhulde tablet - 50 mg - lacosamide 50 mg - lacosamide
lacosamide teva 150 mg filmomh. tabl.
teva b.v. - lacosamide 150 mg - filmomhulde tablet - 150 mg - lacosamide 150 mg - lacosamide
lacosamide teva 200 mg filmomh. tabl.
teva b.v. - lacosamide 200 mg - filmomhulde tablet - 200 mg - lacosamide 200 mg - lacosamide
lacosamide teva 100 mg filmomh. tabl.
teva b.v. - lacosamide 100 mg - filmomhulde tablet - 100 mg - lacosamide 100 mg - lacosamide
lacosamide accord
accord healthcare s.l.u. - lacosamide - epilepsie - van anti-epileptica, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide ucb
ucb pharma s.a. - lacosamide - epilepsies, gedeeltelijk - van anti-epileptica, - lacosamide ucb is geïndiceerd als monotherapie en adjuvante therapie bij de behandeling van partieel beginnende aanvallen met of zonder secundaire generalisatie bij volwassenen, adolescenten en kinderen vanaf 4 jaar en ouder met epilepsie.
lacosamide eg 50 mg filmomh. tabl.
eg sa-nv - lacosamide 50 mg - filmomhulde tablet - 50 mg - lacosamide 50 mg - lacosamide
lacosamide eg 100 mg filmomh. tabl.
eg sa-nv - lacosamide 100 mg - filmomhulde tablet - 100 mg - lacosamide 100 mg - lacosamide
lacosamide eg 150 mg filmomh. tabl.
eg sa-nv - lacosamide 150 mg - filmomhulde tablet - 150 mg - lacosamide 150 mg - lacosamide